Biotech · Private company
Checkmate Pharmaceuticals
Track this companyFree. Adds Checkmate Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. NivolumabPHASE2 · COMPLETED · started Sep 2, 2020ClinicalTrials.gov NCT04401995 · fetched Nov 12, 2026
- CMP-001 for Relapsed and Refractory LymphomaPHASE1_PHASE2 · TERMINATED · started Jan 31, 2020ClinicalTrials.gov NCT03983668 · fetched Nov 12, 2026
- CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node DiseasePHASE2 · COMPLETED · started Aug 8, 2018ClinicalTrials.gov NCT03618641 · fetched Nov 12, 2026